Curriculum Vitae
Carlos Jorge Azevedo Costa Ribeiro
Identification
Personal identification
- Full name
- Carlos Jorge Azevedo Costa Ribeiro
Citation names
- Ribeiro, Carlos J A
Author identifiers
- Ciência ID
- 241A-31B3-A5D2
- ORCID iD
- 0000-0001-8002-910X
- Google Scholar ID
- https://scholar.google.com/citations?hl=en&user=v0pAnYEAAAAJ
- Researcher Id
- ABC-9701-2021
- Scopus Author Id
- 37034824600
Websites
- https://www.linkedin.com/in/carlos-ribeiro-06882870/ (Social media)
- https://toxrun.iucs.cespu.pt/?q=content/carlos-ribeiro (Scholar)
Languages
| Language | Speaking | Reading | Writing | Listening | Peer-review |
|---|---|---|---|---|---|
| Portuguese (Mother tongue) | |||||
| English | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) |
Education
| Degree | Classification | |
|---|---|---|
|
2011/01 - 2015/10
Concluded
|
Farmácia (Doutoramento)
Major in Especialidade: Química Farmacêutica e Terapêutica
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Design and synthesis of small molecule modulators of p53" (THESIS/DISSERTATION)
|
|
|
2007/09 - 2010/12
Concluded
|
Engenharia Farmacêutica (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
Universidade de Lisboa Instituto Superior Técnico, Portugal "Synthesis of spirooxindoles derivatives by 1,3-dipolar cycloaddition" (THESIS/DISSERTATION)
|
18/20 |
|
2004/11 - 2005/05
Concluded
|
Saúde comunitária (Pós-Graduação)
Universidade do Porto, Portugal
Cofanor, Portugal |
|
|
1997/09 - 2003/07
Concluded
|
Ciências Farmacêuticas (Licenciatura)
Universidade do Porto Faculdade de Farmácia, Portugal
|
16/20 |
Affiliation
Science
| Category Host institution |
Employer | |
|---|---|---|
| 2019/07 - 2019/12 | Postdoc (Research) | University of Leeds Faculty of Engineering and Physical Sciences, United Kingdom |
| University of Leeds Faculty of Engineering and Physical Sciences, United Kingdom | ||
| 2016/08 - 2019/06 | Postdoc (Research) | University of Minnesota Center for Drug Design, United States |
| University of Minnesota Center for Drug Design, United States | ||
| 2013/05 - 2013/07 | Visiting Researcher (Research) | University of California Davis, United States |
| University of California Davis, United States | ||
| 2003/02 - 2003/06 | Visiting Researcher (Research) | University of Strathclyde, United Kingdom |
| University of Strathclyde, United Kingdom |
Positions / Appointments
| Category Host institution |
Employer | |
|---|---|---|
| 2021/06/01 - Current | Product developer | Avextra Portugal, SA, Portugal |
| 2021/06/01 - Current | Product developer | Psilo Pharma Inc, Canada |
| 2008/06 - 2008/12 | Diretor Técnico | Pharmion - Sucursal Em Portugal, Portugal |
| 2007/03 - 2007/09 | Farmacêutico Adjunto | Farmácia Sanil, Portugal |
| 2003/09 - 2006/12 | Farmacêutico Adjunto | Farmácia Arnoso, Portugal |
Projects
Contract
| Designation | Funders | |
|---|---|---|
| 2016/04/01 - 2019/04/01 | Targeting p53 family proteins: on the route to new anticancer agents
PTDC/DTP-FTO/1981/2014
Post-doc Fellow
Universidade do Minho, Portugal
Universidade de Coimbra, Portugal Universidade Nova de Lisboa Associação para a Inovação e Desenvolvimento da FCT, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
Outputs
Publications
| Book chapter |
|
| Conference poster |
|
| Journal article |
|
| Thesis / Dissertation |
|
Activities
Oral presentation
| Presentation title | Event name Host (Event location) |
|
|---|---|---|
| 2018/10 | A Novel Chemotype as Hepatitis B Virus Capsid Assembly Effectors | 6th annual 'Wisc-e-sota' symposium
University of Minnesota and University of Wisconsin (La Crosse, United States)
|
| 2015/12 | Spirooxadiazoline Oxindoles with Promising in Vitro Antitumor Activities | 11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry
Sociedade Portuguesa de Química (Porto, Portugal)
|
| 2014/12/09 | Synthesis and Biological Evaluation of Spiroisoxazoline and Spirooxadiazoline Oxindoles as Anticancer Agents | EFMC-YMCS 2014. 1st EFMC Young Medicinal Chemist Symposium
Universidade de Lisboa, Faculdade de Farmácia (Lisboa, Portugal)
|
| 2014/05 | Synthesis and Biological Evaluation of Spiroisoxazoline Oxindoles as Anticancer Agents | 4rd Portuguese Young Chemists Meeting
Portuguese Chemical Society (SPQ) and Universidade de Coimbra, Faculdade de Ciências e Tecnologia (Coimbra, Portugal)
|
| 2013/12/20 | Spiroisoxazoline Oxindoles: a New Class of p53-MDM2 Interaction Inhibitors | 4th iMed.UL Post-Graduate Students Meeting
Universidade de Lisboa, Faculdade de Farmácia (Lisboa, Portugal)
|
| 2013/09 | Presentation of Literature Published in the Field of Cancer Stem cells - Chemical Point of View. | COST Action CM1106: Chemical Approaches to Targeting Drug Resistance in Cancer Stem Cells. 2nd Working Group Meeting.
(Varsóvia, Poland)
|
| 2012/07 | Synthesis and Biological Evaluation of New Spiroisoxazoline Oxindoles as Potential Anticancer Agents | 32nd Edition of the European School of Medicinal Chemistry (ESMEC)
European School of Medicinal Chemistry (Urbino, Italy)
|
| 2012/05 | Efficient Synthesis of New Spiroisoxazoline Oxindoles | 3rd Portuguese Young Chemists Meeting
Portuguese Chemical Society (SPQ) and Universidade do Porto, faculdade de Ciências (Porto)
|
| 2011/11 | Structural Characterization of a Novel Spiroisoxazoline Oxindole | Modern Methods of Structure Elucidation (MMSE)
Universidade de Lisboa, Instituto Superior Técnico (Lisboa, Portugal)
|
Distinctions
Other distinction
| 2003 | Eng. António de Almeida award for finishing the degree with final grade of 16/20, the highest, in the year 2002/2003, in Pharmaceutical
Sciences, Faculty of Pharmacy - University of Porto
Fundação Engenheiro António de Almeida, Portugal
|